XM无法为美国居民提供服务。
S
S

Sobi

交易方向

交易者偏好

技术摘要

每小时

市场新闻

SOBI, Enable Injections Announce Development and Distribution Agreement

BRIEF-SOBI, Enable Injections Announce Development and Distribution Agreement Sept 12 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST : SOBI® AND ENABLE INJECTIONS ANNOUNCE AGREEMENT TO DEVELOP AND DISTRIBUTE ASPAVELI® IN COMBINATION WITH ENFUSE® IN SOBI TERRITORIES Source text for Eikon: ID:nWkr4Gc1vJ Further company coverage: SOBIV.ST
S

Danske Bank, Lotus Bakeries NV, Vesuvius

EUROPE RESEARCH ROUNDUP-Danske Bank, Lotus Bakeries NV, Vesuvius Aug 13 (Reuters) - Securities analysts revised their ratings and price targets on several European companies, including Danske Bank, Lotus Bakeries NV and Vesuvius, on Tuesday. HIGHLIGHTS * Abrdn Plc ABDN.L : Morgan Stanley raises target price to 160p from 149p * Danske Bank DANSKE.CO : Morgan Stanley initiates coverage with overweight rating * Lotus Bakeries NV LOTB.BR : Berenberg raises target price to EUR 10,300 from EUR 9,000 *
A
A
A
B
C
D
E
F
H
H
K
L
M
M
N
O
S
S
S
S
S
H
A
S
U

SOBI, Apellis Announce Positive Topline Results From VALIANT Study

BRIEF-SOBI, Apellis Announce Positive Topline Results From VALIANT Study Aug 8 (Reuters) - Swedish Orphan Biovitrum AB (publ) SOBIV.ST : SOBI AND APELLIS ANNOUNCE POSITIVE TOPLINE RESULTS FROM PHASE 3 VALIANT STUDY OF PEGCETACOPLAN IN C3G AND PRIMARY IC-MPGN MET PRIMARY ENDPOINT, ACHIEVING STATISTICALLY SIGNIFICANT 68% (P PLANS TO SUBMIT A MARKETING APPLICATION WITH EUROPEAN MEDICINES AGENCY (EMA) IN 2025 APELLIS ALSO PLANS TO SUBMIT A SUPPLEMENTAL NEW DRUG APPLICATION TO U.S.
S

Top of the Street: Sika, Haleon, Anglo American, VAT Group

BUZZ-Top of the Street: Sika, Haleon, Anglo American, VAT Group A round-up of notable broker activity this morning from Europe's top-ranked* analysts: ** Stifel raises Swiss chemicals maker Sika SIKA.S to "buy" from "hold" after it increased its PT to CHF 270, which implies an upside of 11%, following the recent share price drop ** Goldman Sachs cuts consumer healthcare company Haleon HLN.L to "neutral" from "buy", as it sees limited catalysts to drive near term price performance, with Pfizer's
D
N
P
S
S
A

Jefferies cuts SOBI to 'hold' as competition weighs

BUZZ-Jefferies cuts SOBI to 'hold' as competition weighs ** Jefferies cuts Swedish Orphan Biovitrum SOBIV.ST to "hold" from "buy", citing increasing competition pressure for the Swedish drug maker ** Brokerage sees Merck's MRK.N positive data for antibody against lung infections caused by respiratory syncytial virus (RSV), clesrovimab, as a downsid
G
S

商品详情

热门商品

免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。

所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。

本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里

风险提示: 您的资金存在风险。杠杆商品并不适合所有客户。请详细阅读我们的风险声明